Related Experiment Video
Updated: Nov 7, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation
1Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun 130021, China.
Chimeric antigen receptor (CAR)-T cell therapy shows promise for cancer treatment but faces challenges like limited effectiveness and persistence, especially in solid tumors. This review explores cutting-edge breakthroughs and strategies to overcome these obstacles for improved CAR-T therapy.
Area of Science:
- Immunotherapy
- Cellular Therapy
- Oncology
Background:
- Chimeric antigen receptor (CAR)-T cell therapy has achieved success in hematologic malignancies.
- Significant challenges remain, including limited antitumor activity, poor CAR-T cell persistence, and issues with clinical security and accessibility, particularly for solid tumors.
Purpose of the Study:
- To review recent advancements in CAR-T cell therapy for cancer treatment.
- To discuss strategies for overcoming current limitations in CAR-T therapy.
- To provide a reference for future research and clinical applications.
Main Methods:
- Literature review of cutting-edge breakthroughs in CAR-T therapy.
- Analysis of independent and combined strategies for CAR-T cell application.
- Discussion of solutions addressing challenges in CAR-T therapy.
Main Results:
- Various strategies have been proposed and validated to enhance CAR-T cell efficacy and persistence.
- Both standalone and combination approaches show potential for CAR-T therapy.
- Progress has been made in addressing security and accessibility concerns.
Conclusions:
- CAR-T cell therapy holds significant promise for cancer treatment, with ongoing research addressing key limitations.
- Innovative strategies are crucial for improving the therapeutic index and expanding the application of CAR-T cells, especially in solid tumors.
- Further development is needed to fully realize the potential of CAR-T therapy in clinical practice.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer

